4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-015782
CHIEF ACCOUNTING OFFICER sold 15,211 shares at $28.75 ($437,316)
- CHIEF ACCOUNTING OFFICER acquired 15,211 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-06-03 | Option exercise 10b5-1 | +15,211 | $15.50 | $235,771 | 47,757 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-06-03 | Sale 10b5-1 | −15,211 | $28.75 | $437,316 | 32,546 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-06-03 | Option exercise · Share Option 10b5-1 | −15,211 | 791 | D | ||
| Open-market sales · 15,211 sh · avg $28.75 · $437,316 | |||||||
Loading xslF345X05/form4-06052025_080606.xml…